253 / 490
251
POSTERS AND ELECTRONIC POSTERS
| PROGRAMME AND EXHIBITION GUIDE
ELECTRONIC POSTERS
> Long term patient reported urinary function following external beam
radiotherapy for prostate cancer
S. Chin (Australia), A. Hayden, V. Gebski, S. Cross, S. Turner
EP-1376
> Consistency of cone beam CT-derived bladder volume and inflow
during localized prostate cancer IMRT
C.J. HO (UK), C.K. McGarry, J.Y. Sun, C.A. Lyons, R.B. King,
S. Jain, A.R. Hounsell, J.M. O’Sullivan
EP-1377
> Should pelvic radiotherapy be tailored to early patient-reported
gastrointestinal toxicity?
M. Reis Ferreira (UK), S. Gulliford, K. Thomas, L. Truelove,
H. McNair, D.P. Dearnaley
EP-1378
> SBRT in the treatment of bone metastases in hormone refractary
prostate cancer
S. Grespi (Italy), C. Menichelli, A. Fanelli, P. Ferrazza, G. Pastore,
F. Casamassima
EP-1379
> Primary focal prostate radiotherapy: do all patients really need whole-
prostate irradiation?
B.A. Jereczek-Fossa (Italy), D. Ciardo, G. Petralia, M. Bellomi,
O. De Cobelli, R. Orecchia
EP-1380
> ADC of prostate tumour and normal tissue during radiotherapy after
neoadjuvant hormone therapy
L. Kershaw (UK), A. McPartlin, A. Choudhury, M. Van Herk
EP-1381
> PET/CT and MRI guided salvage radiotherapy after prostatectomy for
prostate cancer
S. Kirste (Germany), J. Bons, N. Volegova-Neher, C. Zamboglou,
K. Henne, W. Schultze-Seemann, H.C. Rischke, A.L. Grosu
EP-1382
> PSA kinetics in prostate cancer patients after SBRT radiotherapy using
CyberKnife.
M. Konkol (Poland), A. Galuba, P. Milecki, A. Skrobala, A. Jodda,
M. Adamczyk, J. Litoborska
EP-1383
> Acute toxicity hypofractionated-IMRT vs standard radiotherapy in
prostate cáncer: comparative study
J. Valero Albarran (Spain), R. Guimaraes Domingos da Silva, S. Payano,
A. Montero, E. Sánchez, X. Chen, O. Hernando, M. García Aranda,
R. Ciervide, M. Lopez, M. Rubio
EP-1384